124 related articles for article (PubMed ID: 15705066)
1. Molecular pathways in bladder cancer: part 2.
Bryan RT; Hussain SA; James ND; Jankowski JA; Wallace DM
BJU Int; 2005 Mar; 95(4):491-6. PubMed ID: 15705066
[No Abstract] [Full Text] [Related]
2. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer.
Dasgupta S; Hoque MO; Upadhyay S; Sidransky D
Cancer Res; 2008 Feb; 68(3):700-6. PubMed ID: 18245469
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer.
Patel NS; Dobbie MS; Rochester M; Steers G; Poulsom R; Le Monnier K; Cranston DW; Li JL; Harris AL
Clin Cancer Res; 2006 Aug; 12(16):4836-44. PubMed ID: 16914569
[TBL] [Abstract][Full Text] [Related]
6. Bladder cancer angiogenesis and metastasis--translation from murine model to clinical trial.
Black PC; Dinney CP
Cancer Metastasis Rev; 2007 Dec; 26(3-4):623-34. PubMed ID: 17726580
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder.
Dickinson AJ
Br J Urol; 1996 Nov; 78(5):808. PubMed ID: 8976796
[No Abstract] [Full Text] [Related]
8. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
Suzuki K; Morita T; Tokue A
Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
[TBL] [Abstract][Full Text] [Related]
9. An endogenous inhibitor of angiogenesis derived from a transitional cell carcinoma: clipped beta2-glycoprotein-I.
Beecken WD; Engl T; Ringel EM; Camphausen K; Michaelis M; Jonas D; Folkman J; Shing Y; Blaheta RA
Ann Surg Oncol; 2006 Sep; 13(9):1241-51. PubMed ID: 16955386
[TBL] [Abstract][Full Text] [Related]
10. The role of the endothelin axis and microvessel density in bladder cancer - correlation with tumor angiogenesis and clinical prognosis.
Herrmann E; Bögemann M; Bierer S; Eltze E; Toma MI; Köpke T; Hertle L; Wülfing C
Oncol Rep; 2007 Jul; 18(1):133-8. PubMed ID: 17549358
[TBL] [Abstract][Full Text] [Related]
11. Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets.
Ahmed HU; Arya M; Patel HR
Expert Rev Anticancer Ther; 2005 Dec; 5(6):1011-22. PubMed ID: 16336092
[TBL] [Abstract][Full Text] [Related]
12. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
[TBL] [Abstract][Full Text] [Related]
13. Primary invasive urothelial carcinoma of the bladder resembling invasive lobular carcinoma of the breast: a potential diagnostic pitfall of an unusual high-grade bladder neoplasia.
Galia A; Amico P; Emmanuele C; Tranchina MG; Pepe P; Fraggetta F
Pathol Res Pract; 2013 May; 209(5):327-9. PubMed ID: 23598071
[No Abstract] [Full Text] [Related]
14. Overexpression of alpha-defensin is associated with bladder cancer invasiveness.
Holterman DA; Diaz JI; Blackmore PF; Davis JW; Schellhammer PF; Corica A; Semmes OJ; Vlahou A
Urol Oncol; 2006; 24(2):97-108. PubMed ID: 16520271
[TBL] [Abstract][Full Text] [Related]
15. Potential for molecular-targeted therapy targeting human epidermal growth factor receptor-2 for invasive bladder cancer.
Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Inoue Y; Noguchi H; Honda N
Oncol Rep; 2007 Jul; 18(1):3-7. PubMed ID: 17549338
[TBL] [Abstract][Full Text] [Related]
16. HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion.
Lokeshwar VB; Cerwinka WH; Lokeshwar BL
Cancer Res; 2005 Mar; 65(6):2243-50. PubMed ID: 15781637
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
J Urol; 2007 Feb; 177(2):481-7; discussion 487. PubMed ID: 17222615
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathways in bladder cancer: part 1.
Bryan RT; Hussain SA; James ND; Jankowski JA; Wallace DM
BJU Int; 2005 Mar; 95(4):485-90. PubMed ID: 15705065
[No Abstract] [Full Text] [Related]
19. Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer.
Matsumoto K; Satoh T; Irie A; Ishii J; Kuwao S; Iwamura M; Baba S
Urology; 2008 Aug; 72(2):444-9. PubMed ID: 18313120
[TBL] [Abstract][Full Text] [Related]
20. [Studies on invasiveness and metastasis of bladder cancer. Ist report. A pathologic study of blood vessel and lymyhatics invasion (author's transl)].
Numasawa K; Sugano O; Kubota Y; Saito M; Adachi K; Kawamura S; Suzuki K
Nihon Hinyokika Gakkai Zasshi; 1981 Aug; 72(8):1035-9. PubMed ID: 7321350
[No Abstract] [Full Text] [Related]
[Next] [New Search]
